QR Code-Based Track and Trace System for Medicines

Why in News?

Recently, The Central Government has mandated that vaccines, antimicrobials, narcotics and addictive drugs, and anti-cancer medicines carry a unique QR code or barcode to enable end-to-end tracking of every vial or blister pack. The system will be implemented in phases by July 2027 (vaccines, narcotics, anti-cancer drugs) and July 2028 (antimicrobials) to strengthen drug safety and combat counterfeit medicines.

What is the QR Code-Based Track and Trace System?

The Track and Trace System is a digital mechanism that assigns every medicine pack a unique identification code, enabling regulators and manufacturers to monitor its movement throughout the supply chain—from manufacturing to distribution and retail.

Manufacturers of medicines listed under Schedule H2 of the Drugs Rules, 1945 are required to affix a QR code or barcode on the primary packaging (or secondary packaging where space is limited).

The QR code contains details such as:

• • Brand and generic name of the drug
  • Manufacturer's name and address
  • Batch number
  • Manufacturing and expiry dates
  • Manufacturing licence number
  • Unique identification number for each unit

Why is the System Needed?

The primary objective is to prevent counterfeit and substandard medicines, which pose serious risks to public health. The system helps:

• • Detect fake or diluted medicines.
  • Prevent reuse of genuine packaging for counterfeit drugs.
  • Identify contamination or tampering in the supply chain.
  • Enable rapid product recalls.
  • Improve patient safety and regulatory transparency.

The need has become more significant following incidents involving counterfeit high-value medicines, including expensive cancer drugs.

Benefits:

• • Strengthens drug authentication and traceability.
  • Enhances regulatory oversight by enabling real-time tracking.
  • Reduces circulation of spurious medicines.
  • Improves consumer confidence in pharmaceutical products.
  • Facilitates efficient recalls during quality failures.
  • Supports India's pharmaceutical exports by improving global trust.

Challenges:

• • High implementation costs for manufacturers, especially small pharmaceutical firms.
  • Need for robust digital infrastructure across the supply chain.
  • Risk of incorrect or delayed data entry affecting product verification.
  • Requirement for coordination among manufacturers, distributors, retailers, and regulators.

Significance for Drug Regulation:

The initiative will strengthen the functioning of the Central Drugs Standard Control Organisation (CDSCO) and improve India's pharmaceutical regulatory framework. Enhanced traceability aligns with the World Health Organization (WHO) Global Benchmarking Tool, helping India move towards Maturity Level 4, the highest regulatory standard. This would improve the international acceptance of Indian medicines and reinforce India's position as a global pharmaceutical hub.

Conclusion:

The QR code-based track and trace system marks a significant step towards ensuring safe, authentic, and quality-assured medicines. By enhancing transparency across the pharmaceutical supply chain, it will strengthen public health, improve regulatory efficiency, and help curb the growing menace of counterfeit drugs in India.